Dr. David Pierre Beynet, MD

Dr. Beynet practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Beynet's NPI, 1679651590, was assigned on November 1, 2006. Dr. Beynet graduated from Stanford University School Of Medicine in 2004. Dr. Beynet holds California license A95507.

Dr. Beynet's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Beynet's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Beynet to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beynet practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Beynet's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Beynet is board certified in dermatology by the American Board of Dermatology. Dr. Beynet is licensed in California.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal and contact dermatitis among the conditions Dr. Beynet treats.

CMS data shows 1,747 Medicare services from Dr. Beynet across 20 procedure codes in 2024, for 498 Medicare patients. Medicare paid $648,846 for them. Every service was in an office.

CMS counts 498 Medicare patients who saw Dr. Beynet in 2024. The largest group is 75 to 84, with 220 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Beynet's median patient age at 73, with 37% women.

In 2024, Dr. Beynet wrote 844 Medicare Part D claims for 518 patients. 100% of them were for generic drugs. CMS names the drug for 812 of them, across 6 drugs with 11 or more claims each, at $7,018 in total drug cost. In 2023, CMS named 553 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Beynet for performance year 2024, reported as part of a group. Dr. Beynet accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 163 procedures of melanoma (skin cancer) excision by Dr. Beynet, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Beynet, published from 2002 to 2019. 2015 was the busiest year, with 2. The most frequent topics are Immunohistochemistry, Biopsy, Needle and Cosmetic Techniques. Dr. Beynet has published most often in Arch Dermatol. Dr. Beynet's most frequent co-authors are Nima M. Gharavi, MD, PhD, Andrew D. Breithaupt, MD and Michael L. Goris, MD.

CMS Open Payments shows 11 general payments to Dr. Beynet from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $392.

Dr. Beynet graduated from Stanford University School Of Medicine in 2004.

Dr. Beynet is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.